| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | 423.60 | -92.60 | 195.70 | -241.00 |
| Net Changein Cash | 78.90 | 49.60 | -61.50 | 20.80 |
| Cash Taxes Paid | 397.70 | 372.60 | 286.30 | 177.50 |
| Net Income/ Starting Line | 1,490.80 | 2,291.40 | 1,673.50 | 861.90 |
| Total Cash Dividends Paid | -90.20 | -107.80 | -170.80 | -100.40 |
| Changesin Working Capital | 247.70 | -572.30 | -595.70 | -114.80 |
| Cashfrom Operating Activities | 1,768.30 | 1,696.80 | 1,211.60 | 849.10 |
| Cash Interest Paid | 35.90 | 17.60 | 18.10 | 14.20 |
| Cashfrom Financing Activities | 297.50 | -210.70 | -246.90 | -363.00 |
| Issuance( Retirement)of Stock Net | 0.00 | 7.30 | -253.70 | -7.40 |
| Depreciation/ Depletion | 206.60 | 235.20 | 186.80 | 163.80 |
| Other Investing Cash Flow Items Total | -1,690.60 | -902.90 | -674.00 | -271.50 |
| Capital Expenditures | -391.10 | -511.60 | -358.70 | -205.60 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | 94.80 | -22.00 | 6.50 | 11.80 |
| Non- Cash Items | -176.80 | -257.50 | -53.00 | -61.80 |
| Financing Cash Flow Items | -35.90 | -17.60 | -18.10 | -14.20 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -2,081.70 | -1,414.50 | -1,032.70 | -477.10 |
Natco Pharma Dividend Natco Pharma Bonus Natco Pharma News Natco Pharma AGM Natco Pharma Rights Natco Pharma Splits Natco Pharma Board Meetings Natco Pharma Key Metrics Natco Pharma Shareholdings Natco Pharma Profit Loss Natco Pharma Balance Sheet Natco Pharma Q1 Results Natco Pharma Q2 Results Natco Pharma Q3 Results Natco Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.